Pathogen proteomes during infection: A basis for infection research and novel control strategies

被引:33
作者
Bumann, Dirk [1 ]
机构
[1] Univ Basel, Biozentrum, CH-4056 Basel, Switzerland
关键词
Bacterial infection; Pathogen metabolism; Vaccine antigen identification; SALMONELLA GENE-EXPRESSION; ESCHERICHIA-COLI; PERSISTENT INFECTION; SEROVAR TYPHIMURIUM; PROTEIN; IDENTIFICATION; PHOSPHOPEPTIDES; RESISTANCE; RESPONSES; SELECTION;
D O I
10.1016/j.jprot.2010.08.004
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
Infectious diseases cause tremendous mortality and morbidity worldwide. Rising antimicrobial resistance and the lack of new drugs cause an increasingly alarming crisis in infectious disease control. New system-level approaches are likely to help understand complex host/pathogen interactions as a basis for rational development of novel antibiotics and vaccines. Proteome analysis of pathogens in infected tissues comprehensively reveals functionally relevant pathogen activities during infection. It also highlights potential targets for antimicrobial chemotherapy as well as promising antigens for vaccination. Integration of these data with complementary large-scale data helps to further prioritize candidates for in-depth experimental analysis. Here, I discuss some of these approaches with a special emphasis on the model pathogen Salmonella. (C) 2010 Elsevier B.V. All rights reserved.
引用
收藏
页码:2267 / 2276
页数:10
相关论文
共 65 条
  • [1] Multidrug-resistant Salmonella enterica serovar Typhi isolates with high-level resistance to ciprofloxacin in Dhaka, Bangladesh
    Ahmed, Dilruba
    D'Costa, Liton T.
    Alam, Khorshed
    Nair, G. Balakrish
    Hossain, M. Anowar
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2006, 50 (10) : 3516 - 3517
  • [2] Metabolic efficiency and amino acid composition in the proteomes of Escherichia coli and Bacillus subtilis
    Akashi, H
    Gojobori, T
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2002, 99 (06) : 3695 - 3700
  • [3] Antimicrobial resistance in nontyphoidal Salmonella
    Alcaine, Samuel D.
    Warnick, Lorin D.
    Wiedmann, Martin
    [J]. JOURNAL OF FOOD PROTECTION, 2007, 70 (03) : 780 - 790
  • [4] Management of multidrug-resistant enterococcal infections
    Arias, C. A.
    Contreras, G. A.
    Murray, B. E.
    [J]. CLINICAL MICROBIOLOGY AND INFECTION, 2010, 16 (06) : 555 - 562
  • [5] BALEMANS W, NATURE, V463, pE4
  • [6] Essentiality of FASII pathway for Staphylococcus aureus
    Balemans, Wendy
    Lounis, Nacer
    Gilissen, Ron
    Guillemont, Jerome
    Simmen, Kenny
    Andries, Koen
    Koul, Anil
    [J]. NATURE, 2010, 463 (7279) : E3 - E4
  • [7] The use of genomics in microbial vaccine development
    Bambini, Stefania
    Rappuoli, Rino
    [J]. DRUG DISCOVERY TODAY, 2009, 14 (5-6) : 252 - 260
  • [8] Robust Salmonella metabolism limits possibilities for new antimicrobials
    Becker, D
    Selbach, M
    Rollenhagen, C
    Ballmaier, M
    Meyer, TF
    Mann, M
    Bumann, D
    [J]. NATURE, 2006, 440 (7082) : 303 - 307
  • [9] Typhoid and paratyphoid fever
    Bhan, MK
    Bahl, R
    Bhatnagar, S
    [J]. LANCET, 2005, 366 (9487) : 749 - 762
  • [10] Bad Bugs, No Drugs: No ESKAPE! An Update from the Infectious Diseases Society of America
    Boucher, Helen W.
    Talbot, George H.
    Bradley, John S.
    Edwards, John E., Jr.
    Gilbert, David
    Rice, Louis B.
    Scheld, Michael
    Spellberg, Brad
    Bartlett, John
    [J]. CLINICAL INFECTIOUS DISEASES, 2009, 48 (01) : 1 - 12